Fda Approved More Doses of Covid-19 Vaccine for Weak Immune Patients

The FDA has made it possible to give a second dose of the Pfizer/BioNTech and Moderna Covid-19 vaccines to people who have a weak immune system. These people include those who have had a solid organ transplant or are diagnosed with conditions that make them feel like they have no immune system.

The country has caught a nasty virus. It is called COVID-19, and it can make people very sick. The FDA looked at data and found that they are less likely to get sick when people have a third dose of certain vaccines.

There are three different kinds of vaccines that you can use in emergencies. There is the two-dose Pfizer/BioNTech vaccine for people 12 and older, the two-dose Moderna vaccine for 18 or older, and a single shot from Johnson & Johnson for people 18 or older.

Three of these vaccines are approved by the FDA. Pfizer’s vaccine is not fully supported yet.

Some people need more than one dose of the Covid-19 vaccine. The CDC will talk about how to do this and when during their meeting on Friday.

As the committee prepares to vote on whether more doses of the vaccine should be recommended for people with weak immune systems, some groups are concerned about how this could affect a person’s ability to fight off disease.

Some believe that these vaccines can boost an individual’s immunity and help them battle against common illnesses like flu and cold symptoms, which often strike those who have weaker immune systems or other health conditions.

Suppose these drugs prove effective in reducing rates of illness and hospital stays. In that case, they may even provide relief financially because it would cost less money per patient than paying for care at hospitals when individuals get sicker due to being confined there by doctors’ orders while trying to recover.

Moderna said in an email, “We think that every person should have access to our vaccines.” They also said: “The need for a third dose is quite rare, and most people will not require it.”

An alarming study by Johns Hopkins researchers found that immunocompromised people who are vaccinated are 485 times more likely to end up in the hospital or die from Covid-19. This is undoubtedly significant and should be addressed by our fellow scientists so as not to further contribute to this growing epidemic.

The Centers for Disease Control and Prevention estimate around nine million of us in America suffer from an immune system deficiency. Either because we’ve contracted a disease that makes our body incapable of fighting off an infection or our medicines.

When Covid-19 vaccines were first released, there was hope that the vaccine would protect people who had not received them. That didn’t happen because about a third of eligible people in America have not even been vaccinated once. Hence, they are susceptible to contracting the virus from someone else.

Covid-19 is one of many new diseases popping up lately due to China, which has left some sickened by its effects on their community. Still, while other viruses only affect children or elderly citizens, COVID-19 affects everyone equally regardless of age group. We’re still trying to understand more fully every day, leaving families devastated when loved ones succumb to this vicious contagious disease across our country.

The FDA also recommends immunocompromised individuals maintain other precautions to avoid contracting the flu. Immunocompromised people should stay away from sick people, but they should also wear masks and gloves.

For example, a person with HIV should not be in the same room as someone who might have been exposed to measles because people with compromised immune systems are more vulnerable to contracting those diseases than healthy persons.

FDA recommends that those close to immunocompromised people (such as their caregivers) should get vaccinated themselves, too. FDA’s advice is a must-listen for everyone from friends and family members of patients going through cancer treatment; to someone who fights HIV/AIDS or other types of medical procedures with immune-compromising conditions.

The FDA now recommends immunocompromised patients regularly check in with their doctors about monoclonal antibody treatment options because this will be key to fighting off the new forms of the virus successfully. While that can be an effective treatment for patients with weaker immune systems, the alternative is just as frightening; thousands of people have already lost their lives to COVID-19, and many more will surely lose their lives.

You might also like
Leave A Reply
Please rate

Your email address will not be published.